David Facklam, MS has been appointed senior director, Regulatory and Scientific Affairs at CTI Clinical Trial and Consulting Services. Mr. Facklam has more than 30 years of experience in clinical drug development. Prior to joining the company, he held positions of increasing responsibility at Astellas Pharma, most recently serving as global head and vice president of Global Clinical Science. As a senior leader, he provided oversight and strategic input across clinical programs in transplantation...